Fosun Pharma Launches AI-Driven PharmAID Platform for Enhanced Drug Development

Fosun Pharma has introduced its self-developed PharmAID decision intelligence platform, integrating advanced AI technologies to boost drug R&D efficiency, announced in a press release. The platform is designed to enhance decision-making accuracy and accelerate the transformation of R&D achievements.

The PharmAID platform incorporates global leading large model technologies and connects with Deepseek R1, aiming to improve drug commercial value-assisted decision-making capabilities. It enhances drug R&D efficiency by integrating various predictive and analytical tools, such as point prediction, conformational prediction, and toxicology optimization.

Additionally, the platform offers AI translation and medical writing features, significantly improving information retrieval and writing efficiency. Fosun Pharma's initiative marks a significant step in the AI transformation of the pharmaceutical industry, aiming to lead innovation and transformation with its first self-developed AI decision intelligence platform.